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Folding of newly synthesized proteins in vivo is believed to be facilitated by the 
cooperative interaction of a defined group of proteins known as molecular chaperones. 
We investigated the direct interaction of chaperones with nascent polypeptides in the 
cytosol of mammalian cells by multiple methods. A new approach using a polyclonal 
antibody to puromycin allowed us to tag and capture a population of truncated nascent 
polypeptides with no bias as to the identity of the bound chaperones. In addition, 
antibodies that recognize the cytosolic chaperones hsp70, CCT (TRiC), hsp40, p48 (Hip), 
and hsp90 were compared on the basis of their ability to coprecipitate nascent polypep­
tides, both before and after chemical cross-linking. By all three approaches, hsp70 was 
found to be the predominant chaperone bound to nascent polypeptides. The interaction 
between hsp70 and nascent polypeptides is apparently dynamic under physiological 
conditions but can be stabilized by depletion of ATP or by cross-linking. The cytosolic 
chaperonin CCT was found to bind primarily to full-length, newly synthesized actin, and 
tubulin. We demonstrate and caution that nascent polypeptides have a propensity for 
binding many proteins nonspecifically in celllysates. Although current models of protein 
folding in vivo have described additional components in contact with nascent polypep­
tides, our data indicate that the hsp70 and, perhaps, the hsp90 families are the predom­
inant classes of molecular chaperones that interact with the general population of 
cytosolic nascent polypeptides. 
INTRODUCTION 	 tive folding or aggregation. A class of proteins, now 
referred to as molecular chaperones, is believed to 
It is well known that the primary sequence of amino help prevent such nonproductive interactions by
acids contains all the information necessary for pro­ shielding or stabilizing critical intermediates during
tein folding (Anfinsen, 1973). Inside the cell, however, the folding process (reviewed by Gething and Sam­
the pathway of protein folding is much different from brook, 1992; Georgopoulos and Welch, 1993; Becker 
that observed for the refolding of chemically or ther­ and Craig, 1994; Hendrick and Hartl, 1995; Buchner, 
mally denatured proteins. During the early stages of 1996).
protein synthesis, a nascent polypeptide has not yet The two main classes of molecular chaperones im­
acquired all of the necessary information (i.e., a suit­ plicated in the folding of nascent or newly synthesized
able number of amino acids) to carry out proper fold­ polypeptides are the hsp60 and hsp70 families. Mem­
ing. In addition, the nascent polypeptide must con­ bers of both families are highly conserved, and the 
tend with a crowded environment where incidental expression of some (but not all) members is increased 
binding between the nascent polypeptide and its near­ after different types of metabolic stress, including heat 
est neighbors could lead conceivably to nonproduc­ shock. Because metabolic stress often results in desta­
bilization and aggregation of proteins, molecular 
• Corresponding author. 	 chaperones are thought to play an important role in 
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the renaturation or prevention of such aggregates, in 
addition to their role in facilitating the folding of 
newly synthesized proteins. The latest concepts on the 
mechanisms of action of the hsp60 and the hsp70 
chaperone families recently have been reviewed 
(Hartl, 1996). Members of both families hydrolyze 
ATP in a reaction cycle that alters their conformation 
and thereby modulates their affinity for unfolded 
model substrates. The ATP reaction cycle for hsp70 
(and its bacterial homologue DnaK) may be mediated 
by other proteins in vivo including hsp40 (DnaJ in 
bacteria), p48 (also known as Hip), and GrpE (identi­
fied so far in bacteria and mitochondria only). 
On the basis of chaperone interactions observed in a 
number of different systems including protein trans­
port into isolated mitochondria, refolding experiments 
with purified bacterial chaperones, and in vitro trans­
lation experiments, a model of protein folding in the 
eukaryotic cytosol has been proposed (Frydman et al., 
1994; Frydman and Hartl, 1996). Briefly, Hartl (1996) 
has suggested that nascent polypeptides are first rec­
ognized by and bound to hsp40 (the hdj1 gene prod­
uct). Binding of hsp40 then acts to recruit cytosolic 
hsp70 and thereby facilitate its interaction with the 
nascent polypeptide. For some proteins, a subsequent 
interaction with the cytosolic chaperonin would then 
represent the last step in the protein maturation pro­
cess (Hartl, 1996). Support for different aspects of this 
proposed pathway has been provided by many labo­
ratories. Members of the hsp70 family have been re­
ported to coprecipitate newly synthesized proteins in 
mammalian cells (Beckmann et al., 1990), to cosedi­
ment with nascent polypeptides still bound to poly­
somes (Nelson et al., 1992; Beck and De Maio, 1994), 
and to coprecipitate truncated forms of nascent 
polypeptides after translation in vitro (Frydman et al., 
1994; Hansen et al., 1994; Frydman and Hartl, 1996), 
results that all implicate this chaperone in the early 
events of protein folding. The cytosolic chaperonin 
containing TCP-1, CCT (also referred to as TRiC), is 
distantly related to the hsp60 family and forms a large 
heteromeric ring complex (Kubota et al., 1995). CCT 
has been reported to bind newly synthesized tubulin 
and actin (Stemlicht et al., 1993; Dobrzynski et al., 
1996), to participate in assembly of viral capsids (Lin­
gappa et al., 1994), and to bind nascent forms of both 
firefly luciferase and actin (Frydman et al., 1994; Fryd­
man and Hartl, 1996). Hsp40 and p48 also have been 
reported to bind truncated forms of firefly luciferase, 
suggesting that these proteins may have a chaperone 
function in addition to their roles as cofactors for the 
ATP-hydrolysis cycle of hsp70 (Frydman et al., 1994; 
Hohfeld et al., 1995). 
Experimental approaches for studying protein fold­
ing have become more sophisticated to simulate the 
folding process in vivo. For example, refolding exper­
iments have been performed in the presence of whole 
celllysates (Schumacher et al., 1994; Tian et al., 1996) or 
purified molecular chaperones (Langer et al., 1992; 
Schroder et al., 1993; Szabo et al., 1994; Jakob et al., 
1995; Freeman and Morimoto, 1996), and in vitro 
translation systems have been used to identify pro­
teins that interact with ribosome-bound nascent 
polypeptides (Hendrick et al., 1993; Kudlicki et al., 
1994; Wiedmann et al., 1994; Hesterkamp et al., 1996; 
Reid and Flynn, 1996). All of these approaches are 
dependent on the selection of a model protein, and, 
therefore, the chaperone interactions that are detected 
in these systems do not apply necessarily to the fold­
ing of all proteins. Here we have used a number of 
different approaches to examine the general popula­
tion of nascent polypeptides and their associated mo­
lecular chaperones in the cytosol of mammalian cells. 
Immunoprecipitations with antibodies to a selected 
set of putative molecular chaperones have been car­
ried out to determine which of these proteins interact 
directly with nascent polypeptides. For some experi­
ments, chemical cross-linking was performed in vivo 
to stabilize the nascent chains with their associated 
chaperones before cell lysis and immunoprecipitation 
analysis. In addition, we have continued to exploit the 
use of an antibody to puromycin in our studies, as first 
described in a previous communication (Hansen et al., 
1994). Puromycin is an antibiotic that competes with 
aminoacyl-tRNAs for the A-site of ribosomes. Once 
bound to the ribosome, puromycin becomes co­
valently incorporated into the C terminus of the 
polypeptide chain resulting in premature termination. 
This property of puromycin is used to "tag" nascent 
polypeptides synthesized in vivo and to selectively 
isolate the polypeptides with the polyclonal antibody 
to puromycin. At low concentrations of puromycin, it 
is possible to accumulate a large population of nascent 
polypeptides derived from all the actively translated 
mRNAs in the cell. This heterogeneous collection of 
"puromycyl-polypeptides" may yield information 
about molecular chaperone interactions that is more 
generally characteristic of the folding and maturation 
of cytosolic proteins. 
MATERIALS AND METHODS 
Metabolic Labeling, Puromycin Treatment, and 
Cell Lysis 
HeLa cells were grown in 10% calf serum/DMEM as monolayers on 
culture plates to 50-75% confluency. Typically, 250-500 ,...ci of 
PSSJmethionine (Dupont-New England Nuclear NEG-072, 1000 Ci/ 
mmol) in 5 ml of medium was used for metabolic labeling of a 
10-cm plate of cells. Pulse labeling was performed in methionine­
free DMEM for short times as indicated in the figure legends, and 
the cells were lysed immediately without a chase period. Steady­
state labeling was achieved by incubating the cells with label over­
night (14-18 h) in methionine-free DMEM supplemented with 5% 
complete DMEM and 2% calf serum. Overnight labeling was fol­
lowed by a minimum 4-h chase period in complete medium con­
taining 10% calf serum (no label) to ensure that all labeled proteins 
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were given time to mature before treatment with puromycin and 
cell lysis. Unless noted otherwise, puromycin (Sigma Chemical Co., 
St. Louis, MO) was added to the medium at a concentration of 2 IJ.M 
for 20 min just before cell lysis. For pulse-labeling experiments, 
puromycin and [35S]methionine often were added simultaneously. 
See figure legends for exact duration of pulse labeling and puromy­
cin treatments. Cells were washed with phosphate-buffered saline 
(PBS) and placed at 4°C before being harvested by scraping into 
lysis buffer. Typically, 1 ml of buffer A (20 mM HEPES, pH 7.4, 100 
mM KCl, 2 mM MgCl:z, 1 mM dithiothreitol) containing 0.1% Triton 
X-100 was used per 10-cm plate for detergent lysis. For hypotonic 
lysis, the cells were incubated at 4°C in 10 mM HEPES, 10 mM KCl, 
and 0.1 mM EDTA and allowed to swell at least 15 min while still on 
the plate. The cells then were scraped off the plate, and the lysate 
was adjusted with salts to achieve final buffer A concentrations. 
Lysates were extruded through a 26-gauge needle, incubated for 10 
min at 4°C with 10 U/ml apyrase (Sigma) to deplete ATP, and 
clarified in a microcentrifuge for 10 min. In some experiments, the 
lysates were supplemented with Mg-ATP in place of the apyrase 
treatment (see figure legends). We have found that commercial 
apyrase preparations occasionally are contaminated with a protease 
activity that can be reduced by preincubation with soybean trypsin 
inhibitor at a concentration of 200 ng/unit apyrase. For the exper­
iments in Figure 8, bovine serum albumin (BSA), reduced car­
boxymethylated-BSA, and a5-casein (all from Sigma) were added to 
buffer A+ 0.1% Triton X-100 at a concentration of 10 mg/ml before 
cell lysis. For the proteolysis experiment of Figure 3, TPCK-treated 
trypsin was used (Worthington Biochemical, Freehold, NJ). 
Antibodies and Immunoprecipitation Techniques 
For immunoprecipitation under denaturing conditions, celllysates 
were adjusted with Laemmli sample buffer (final, 1% SDS) and 
heated at 95°C for 5 to 10 min. After clarification in a microcentri­
fuge, the lysate was diluted in RIPA buffer (1% Triton X-100, 1% 
deoxycholate in PBS) such that the final concentration of SDS was 
always less than 0.05%. All samples were preadsorbed with Sepha­
rose CL-4B (Pharmacia, Piscataway, NJ) for 30 min before addition 
of antibody. Incubations with the primary antibody were carried 
out for a minimum of 2 hat 4°C, followed by a 1-h incubation with 
rabbit anti-mouse and rabbit anti-rat secondary antibodies, when 
appropriate. The resulting complexes were captured with protein A 
Sepharose CL-4B (Pharmacia) and washed four times with RIPA 
buffer supplemented with 0.1% SDS. 
For examining protein-protein interactions, immunoprecipitation 
under "native" or "nondenaturing conditions" was performed. In 
this case, the cells were both lysed and diluted in buffer A + 0.1% 
Triton X-100 at 4°C (no SDS, no heating). Antibody additions and 
immunoprecipitations were done as described above, except that 
the final immunoprecipitates were washed four times with buffer A 
supplemented with 1% Triton X-100 and 1% sodium deoxycholate. 
The polyclonal antibody to puromycin was developed by conju­
gating the molecule to a mixture of keyhole limpet hemocyanin and 
hen egg white lysozyme and combining with complete Freund's 
adjuvant before injection of rabbits. A mixture of antibodies was 
used for precipitation of hsc70/hsp70, which included four mouse 
monoclonal antibodies (N6, N15, N21, N33; Milarski et al., 1989), a 
rabbit peptide antibody to hsc70 (Brown et al., 1993), and a rat 
monoclonal antibody 1B5 (Stressgen). The mouse monoclonal anti­
body N27 (Stressgen Biotech Corp., Victoria, British Columbia, Can­
ada) was added to the hsp70 antibody mixture for analysis of 
denatured samples. A mixture of mouse antibodies was used to 
capture p48 (2G6, 1A6, 1001; Prapapanich et al., 1996). The PS 
antibody that recognizes the -y-subunit of CCT was used for non­
denatured samples only (Joly et al., 1994). For immunoprecipitation 
of CCT from denatured samples, a mixture of a rabbit polyclonal 
antibody made against a synthetic peptide of mouse TCP-1 (Lin­
gappa et al., 1994) and the rat monoclonal antibodies 84a and 91a 
(Willison et al., 1989, obtained from Stressgen) was used. A rabbit 
polyclonal antibody to hsp40 was prepared using recombinant hu­
man hsp40 as immunogen (Nagata et al., manuscript in prepara­
tion). A rabbit polyclonal antibody to hsp90 was used for immune­
precipitation of nondenatured samples (W.J.W., unpublished 
observations) and was supplemented with the rat monoclonal an­
tibodies 16F1 and 9D2 (obtained from Stressgen; Lai et al., 1984) for 
the analysis of denatured samples. 
Sizing Chromatography and Sedimentation Analyses 
Sizing chromatography was performed in a 1.0 X 20-cm interior 
diameter column packed with Sephacryl S-400 (Sigma), which was 
equilibrated in buffer A. The excluded volume of the column was 
measured by the elution of phage ,\ DNA, followed by ethidium 
bromide staining. The sedimentation profile of puromycyl-polypep­
tides was achieved by layering a puromycin-treated lysate on a 9-ml 
linear gradient of 10-40% sucrose in buffer A+ 0.1% Triton X-100 
with a 1-ml bottom cushion of 60% sucrose in the same buffer. 
Centrifugation was carried out in a SW-41 rotor (Beckman) for 24 h 
at 39,000 rpm and 4°C. Fractions were collected and analyzed by 
immunoprecipitation as described in the figure legend. Fractions 
containing the 20 s proteasome were determined by immunopre­
cipitation using a polyclonal antibody against one of the proteasome 
subunits (kindly provided by A.L. Goldberg, Harvard University, 
Cambridge, MA). Other sedimentation markers (indicated in Figure 
2) were added directly to the samples and visualized by Coomassie 
stain after SDS-P AGE. For isolation of polysomes, cells were treated 
with 0.1 mg/ml of cycloheximide before hypotonic lysis and lay­
ered on top of 5 ml of 20% sucrose in buffer A + cycloheximide with 
a 2-ml cushion of 70% sucrose in the same buffer. Polysomes were 
found near the interface of the two sucrose layers after a 2-h cen­
trifugation at 39,000 rpm. 
Chemical Cross-Linking In Vivo 
After labeling with PSSlmethionine for the times indicated in Figure 
5, HeLa cells were treated with 0.1 mg/ml of cycloheximide for 2 
min at 37°C to stabilize polysomes. The cells were rinsed with PBS 
containing 0.1 mg/ml cycloheximide and incubated for 10 min at 
ambient temperature (20-22°C) in the same solution supplemented 
with 2 mM DSP, the cell permeable cross-linker dithiobis(succinimi­
dyl-propionate), from Pierce Chemicals (Rockford, IL) (Safiejko­
Mroczka and Bell, 1996). After removal of the DSP solution, the 
reaction was quenched by incubating the cells in 50 mM glycine and 
50 mM Tris, pH 7, for 10 min. The cells then were lysed in Laemmli 
sample buffer without any reducing agent and heated for 10 min at 
75°C. Immunoprecipitation under denaturing conditions was per­
formed using antibodies against the different molecular chaperones 
as given in the figure legends. The final immunoprecipitates were 
boiled in Laemmli sample buffer containing extra reducing agent 
(0.25 M dithiothreitol and 0.25 M /3-mercaptoethanol) to reverse the 
cross-links. 
Electrophoresis Techniques 
Protein samples were analyzed by SDS-PAGE and fluorography on 
gels containing a constant product of acrylamide and bisacrylamide 
(%A x %B = 1.3; Blattler et al., 1972). The isoelectric gradient for 
two-dimensional gels was developed using ampholines of 70% pH 
5-7 and 30% pH 3-10 (Pharmacia). A 12.5% acrylamide gel was 
used for the second dimension. 
RESULTS 
Isolation of Puromycyl-Polypeptides from 
Animal Cells 
Addition of puromycin to growing cells at low con­
centrations resulted in an accumulation of nascent 
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Figure 1. Characterization of the antipuromycin antibody. HeLa 
cells were labeled for 20 min with PSSlmethionine and incubated 
with puromycin as indicated below before cell lysis. Lanes 1-2 are 
starting lysates before immunoprecipitation; lanes 3-8, 10 and 11 
are immunoprecipitations with the puromycin antibody under non­
denaturing conditions. Lane 1, total lysate, no puromycin; lane 2, 
total lysate, 2 ILM puromycin for 30 min; lane 3, 2 ILM puromycin for 
15 min; lane 4, 2 ILM puromycin for 30 min; lane 5, 0.4 !LM puromycin 
for 30 min; lane 6, 2 ILM puromycin for 30 min; lane 7, 10 !LM 
puromycin for 30 min; lane 8, 50 !LM puromycin for 30 min; lane 9, 
immunoprecipitation under denaturing conditions, 2 ILM puromy­
cin for 30 min; lane 10, blocked antibody control, 100 !LM puromycin 
added to diluted lysate before antibody; lane 11, control, preim­
mune serum; lane 12, coprecipitation with antibodies to hsc70/ 
hsp70 under nondenaturing conditions using fivefold more volume 
of the same lysate used in lane 6. 
puromycyl-polypeptides without an immediate 
shutdown of protein synthesis. After a short label­
ing period with [35S)methionine in the presence of 
puromycin, the puromycyl-polypeptides were iso­
lated with a polyclonal antibody specific for puro­
mycin. When analyzed by SDS-PAGE, the puromy­
cin-released polypeptides appeared as a "smear" of 
radiolabeled proteins migrating throughout the gel 
(Figure 1). This heterogeneous appearance is what 
should be expected for a population of polypeptides 
that were derived from all of the active mRNAs in 
the cell by puromycin incorporation at random 
points in translation. Regardless of the brevity of the 
labeling period, a number of discrete bands always 
were observed against this background smear of 
puromycyl-polypeptides in the total cell lysates. 
These discrete bands represent full-length transla­
tion products that were terminated normally in the 
cells without incorporation of the antibiotic (Figure 
1, lanes 1-2). Consistent with this interpretation is 
the fact that few, if any, full-length proteins were 
immunoprecipitated using the antipuromycin anti­
body (Figure 1, lanes 3-9). Production of puromy­
cyl-polypeptides showed little dependence on incu­
bation times beyond 15 min when using a 
concentration of 2 J.LM puromycin (Figure 1, lanes 
3-4), but a strong dependence on puromycin con­
centration for a given incubation time (Figure 1, 
lanes 5-8). In general, 2 J.LM puromycin for 15 to 30 
min yielded the highest accumulation of released 
nascent polypeptides exhibiting a broad distribu­
tion of molecular sizes (Figure 1, lane 6). Concen­
trations of puromycin higher or lower than 2 J.LM 
resulted in nascent polypeptides of either smaller or 
larger average molecular mass, respectively. No ac­
cumulation of nascent polypeptides was observed at 
puromycin concentrations above 50 J.LM, as analyzed 
by 12.5% polyacrylamide gels (Figure 1, lane 8). 
Previous incubation of the serum with free puromy­
cin effectively blocked the capture of puromycyl­
polypeptides (Figure 1, lane 10). Consistent with 
previous observations, puromycin-released nascent 
chains that were captured by the antibody to puro­
mycin were similar in size to those captured using 
antibodies to the cytosolic chaperones hsc70 and 
hsp70 (Beckmann et al., 1990). Note that the consti­
tutive hsc70 (also known as hsp73) and the highly 
stress-inducible hsp70 (hsp72) represent the two 
major cytosolic members of the family and will be 
referred to here collectively as "hsp70." These re­
sults demonstrate the utility of puromycin and con­
firm the specificity of the puromycin antibody for 
the capture and characterization of nascent 
polypeptides. 
Complexes between Nascent Polypeptides and Their 
Chaperones Are Large and Heterogeneous in Size 
The antibody to puromycin was used to examine some 
of the physical characteristics of nascent polypeptides. 
Via both sizing chromatography and velocity sedi­
mentation through a 10-40% sucrose gradient, the 
population of puromycin-released nascent polypep­
tides was observed to be heterogenous in size. When a 
pulse-labeled puromycin-treated lysate was eluted 
from a Sephacryl S-400 sizing column, the majority of 
the puromycyl-polypeptide chains fractionated with 
native molecular masses between the 66 and 670 kDa 
size markers (Figure 2A). Most of the puromycyl­
polypeptides sedimented between 2 and 11 s after 
velocity sedimentation of an identically prepared cell 
lysate (Figure 2B). 
When steady-state labeled puromycin-treated cell 
lysates were fractionated by the same two methods, a 
number of mature proteins were observed to copre­
cipitate with the puromycin antibody (Figure 2, C and 
D). The binding of these proteins may contribute to 
the native size of the nascent polypeptide complexes 
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Nascent Polypeptides and Their Chaperones 
Figure 2. Native size of protein complexes with nascent puromycyl-polypeptides. (A and C) Sizing chromatography with an S-400 column. 
Elution is from left to right. Native size markers are thyroglobulin, 670 kDa; urease, 540 kDa; J3-amylase, 200 kDa; and hemoglobin, 66 kDa. 
(Band D) Sedimentation analysis using a 10-40% sucrose gradient. The bottom of the gradient is at left. Sedimentation markers are the 20 s 
proteasome particle; catalase, 11 s; and cytochrome c, 2 s. See MATERIALS AND METHODS for details of separation by chromatography 
and velocity sedimentation. For A and B, starting lysates were obtained from HeLa cells that had been labeled with [35S)methionine for 20 
min in the simultaneous presence of 2 J.LM puromycin. Fractions containing the pulse-labeled proteins were immunoprecipitated with the 
puromycin antibody under denaturing conditions before analysis on 12.5% acrylarnide gels. For C and D, starting lysates were obtained from 
cells that had been steady-state labeled with PSSlmethionine and chased for 4 h before a 20-rnin incubation with 2 J.LM puromycin. Fractions 
containing steady-state labeled proteins were immunoprecipitated with the puromycin antibody under nondenaturing conditions before 
analysis on 10% acrylamide gels. 
observed in Figure 2, A and B. The molecular masses 
of the individual proteins that coprecipitated with the 
puromycyl-polypeptides were similar after both chro­
matography and sedimentation analyses. Soine of 
these steady-state labeled proteins will be identified 
below. 
Nascent Polypeptides Are More Sensitive to 
Proteases in the Presence of Mg-ATP 
Members of the hsp60 and hsp70 chaperone families 
are known to have ATPase activities that modulate 
their conformation and affinity for bound substrates 
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Figure 3. Sensitivity of nascent polypeptides (A) and mature proteins (B) to degradation by exogenous protease in the absence or presence 
of ATP. Two plates of HeLa cells were labeled with PSS]methionine for the last 10 min of a 20-min incubation with 2 tJ.M puromycin. One 
plate was lysed in the presence of apyrase (-ATP), and the other plate was lysed with 5 mM MgATP in the buffer (+ATP). A stock solution 
of trypsin was added at the indicated concentrations to 20-tJ.l aliquots of lysate and incubated for 30 min at 22°C. Proteolysis was terminated 
by boiling the samples in 3X Laemmli sample buffer and analyzed in duplicate on 12.5% acrylamide gels. (A) Autoradiograph. (B) Gel stained 
with silver reagent. 
(Hartl, 1996). Previous studies have shown that hsp70 
and its bacterial homologue, DnaK, bind to unfolded 
substrates with higher affinity in the ADP-bound state 
(Palleros et al., 1991; Sadis and Hightower, 1992; 
Schmid et al., 1994; McCarty et al., 1995; Theyssen et al., 
1996). Furthermore, it has been demonstrated that 
hsp70 can be captured in a stable complex with nas­
cent polypeptides after ATP levels have been depleted 
in a HeLa cell lysate (Beckmann et al., 1990). To study 
the environment of the nascent polypeptides as a func­
tion of ATP, we examined the accessibility of the 
nascent chains to an added protease. Using trypsin 
digestion as a probe of nascent chain accessibility in 
pulse-labeled cell lysates, proteolysis showed a clear 
dependence on ATP levels (Figure 3A). Specifically, in 
those lysates where ATP had been depleted, the over­
all extent of proteolytic digestion of the radiolabeled 
nascent chains was significantly less as compared with 
those lysates where A TP had been added. Note that 
the discrete bands representing full-length radiola­
beled proteins were not degraded at any of the trypsin 
concentrations used (Figure 3A). Instead, the primary 
target of the added protease was the smear of radio­
active material that represents the nascent polypep­
tides. 
Examination of the proteins in the same celllysates 
by SDS-PAGE and silver staining revealed that the 
protease concentrations that were used did not result 
in global protein degradation (Figure 3B). Very few of 
the mature silver-stained proteins were affected by the 
added protease. It was of interest that hsp90 exhibited 
enhanced degradation in those lysates supplemented 
with A TP. On the other hand, actin degradation was 
observed to increase after ATP depletion. A similar 
pattern of degradation was obtained with cells that 
were treated with cycloheximide (Eggers, 1997). These 
results are consistent with the idea that many of the 
nascent chains form complexes with other macromol­
ecules and that some of these "protective macromol­
ecules" represent members of the ATP-dependent mo­
lecular chaperone families. 
The Predominant Molecular Chaperone Associated 
with Nascent Puromycyl-Polypeptides Is hsp70 
To identify components interacting with nascent 
polypef:tides, HeLa cells were steady state labeled 
with [ 5S]methionine before puromycin treatment. 
The (unlabeled) puromycyl-polypeptides were cap­
tured using the puromycin antibody, and the (radio-

























Figure 4. Identification of proteins that coprecipitate with puro­
mycyl-polypeptides by two-dimensional gel analysis. (A) HeLa cells 
were labeled with PSSlmethionine overnight, chased for 4 h, and 
treated for 30 min with 2 J.LM puromycin before detergent lysis and 
immunoprecipitation with the antipuromycin antibody under non­
denaturing conditions. A one-dimensional profile of the same sam­
ple from another gel is shown at left. (B) Mature proteins were 
labeled and treated with puromycin as in (A), but the cells were 
lysed hypotonically to remove the organelles before immunopre­
cipitation with the antipuromycin antibody. (C) Antipuromycin 
immunoprecipitation from hypotonically lysed cells that were not 
treated with puromycin. Proteins of more basic isoelectric points are 
seen on the right side of each two-dimensional gel. The identified 
proteins are as follows: (1) BiP; (2) grp75; (3) hsc70; (4) hsp70; (5) 
unknown; (6) hsp60; (7) CCT; (8) cytokeratins; (9-11) unknown; 
(Tub) a- and J3-tubulin; (Act) actin. 
labeled) mature proteins that coprecipitated with the 
nascent polypeptides were analyzed by both one and 
two-dimensional gel electrophoresis (Figure 4). The 
proteins that coprecipitated from the whole lysate had 
a similar pattern by SDS-PAGE to those proteins that 
were observed to cofractionate with puromycyl­
polypeptides after sizing chromatography and veloc­
ity sedimentation (compare the one-dimensional gel 
Nascent Polypeptides and Their Chaperones 
profile of Figure 4A to Figure 2, C and D). The major 
coprecipitating proteins are numbered for reference 
(1-11). The identity of many of the coprecipitating 
proteins was determined by immunoprecipitation 
with protein-specific antibodies; the two-dimensional 
gel coordinates of known antigens were aligned with 
the coordinates of the proteins that coprecipitated 
with the puromycyl-polypeptides (Eggers, 1997). The 
most prominent molecular chaperones that coprecipi­
tated with the puromycyl-polypeptides were mem­
bers of the hsp70 family. In addition to the cytosolic 
forms of hsp70, i.e., hsc70 (3) and hsp70 (4), both the 
endoplasmic reticulum form of hsp70, BiP (1), and the 
mitochondrial form of hsp70, grp7S (2), were identi­
fied. Low levels of the mitochondrial chaperonin, 
hsp60 (6), also were detected. Note, however, that 
little of the heteromeric cytosolic chaperonin, CCT (7), 
was coprecipitated (a typical two-dimensional profile 
of CCT is shown in Figure 6B). The capture of the 
compartmentalized chaperones (BiP, grp7S, and the 
mitochondrial hsp60) with the puromycin-released 
nascent chains no longer was observed when the cells 
were lysed via hypotonic treatment, followed by re­
moval of the intact organelles by velocity sedimenta­
tion (Figure 48). In this case, the major components 
that coprecipitated with the cytosol-enriched nascent 
chains were hsc70 and hsp70 (3 and 4). The unidenti­
fied species marked S, 9, and 10 were bound to the 
puromycin antibody nonspecifically because they also 
were precipitated from lysates that had never been 
treated with puromycin (see Figure 4C for example of 
nonspecific binding by S). Of the other proteins that 
coprecipitated with puromycyl-polypeptides, many 
were identified as structural subunits of the cytoskel­
eton, including actin, tubulin, and some intermediate 
filament proteins (8). Conditions for reducing the 
binding of these cytoskeletal proteins are discussed 
later. 
As a complementary approach to identify molecular 
chaperones that interact with nascent polypeptide 
chains, immunoprecipitation studies were carried out 
using antibodies specific for a selected set of molecular 
chaperones. The specificity of the various antibodies 
was confirmed by immunoprecipitation of steady­
state labeled lysates under nondenaturing conditions 
(Figure SA). A collection of antibodies against cytoso­
lic hsp70 precipitated both the constitutive and induc­
ible forms (Figure SA, lane 1). An antibody to the 
y-subunit of CCT resulted in the capture of a number 
of proteins of approximately SS-6S kDa size by 50S­
PAGE, consistent with the heteromeric nature of the 
cytosolic chaperonin particle (Figure SA, lane 2). A 
recently prepared antibody to hsp40 resulted in its 
isolation along with another prominent protein of ap­
proximately 6S kDa, the latter which may represent 
another DnaJ homologue present in animal cells (Na­
gata et al., manuscript in preparation). Antibodies to 
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Figure 5. Ability of antichaperone antibodies to coprecipitate nascent polypeptides under nondenaturing condition (A and B) or under 
denaturing conditions after cross-linking in vivo (C and D). See MATERIALS AND METHODS for description of antibodies used and details 
of cross-linking experiment. (A) Hela cells were steady-state labeled with [35S)methionine, treated with 2 IJ.M puromycin for 20 min, and 
immunoprecipitated under nondenaturing conditions. (B) Hela cells were simultaneously labeled and treated with 2 IJ.M puromycin for 20 
min, followed by immunoprecipitation under nondenaturing conditions. (C) Two plates of Hela cells were steady-state labeled with 
[3SS]methionine and treated with cycloheximide. One plate was used as an uncross-linked control (- ), and the other plate was treated with 
2 mM DSP ( +) before immunoprecipitation under denaturing conditions. (D) Two plates of Hela cells were pulse-labeled for 5 min before 
cross-linking and immunoprecipitation as in (C). In each panel, immunoprecipitations were performed with antibodies which recognize the 
following antigens: (1) hsc70/hsp70; (2) CCT; (3) hsp40; (4) p48; (5) hsp90. Note that the antibodies used for CCT and hsp90 in panels (C) and 
(D) were altered from panels (A) and (B) to include reagents that worked effectively under denaturing conditions. 
p48/Hip brought down an approximately 48-kOa an­
tigen, whereas the polyclonal hsp90 antibody precip­
itated hsp90 along with minor amounts of two other 
proteins. When we examined the relative interaction 
of these different molecular chaperones with pulse­
labeled nascent polypeptides released in vivo via pu­
romycin treatment, a significant amount of the puro­
mycyl-polypeptides was observed to coprecipitate 
with cytosolic hsp70 (Figure 58, lane 1). In contrast, 
antibodies to CCT, hsp40, p48, and hsp90, while cap­
turing their respective full-length newly synthesized 
antigens, failed to coprecipitate the smear of puromy­
cin-released nascent chains. Typically, coprecipitation 
of puromycyl-polypeptides with the pool of antihsp70 
antibodies yielded 15-20% of the total polypeptides 
captured with the polyclonal antibody to puromycin. 
To stabilize ribosome-bound nascent chains with 
their relevant molecular chaperones in the presence of 
physiological concentrations of nucleotides and total 
protein, a cell permeable cross-linker was used. First, 
it was confirmed that the different molecular chaper­
ones could be captured by their respective antibodies 
after chemical cross-linking. Steady-state labeled cells 
were incubated with the membrane-permeable and 
thiol-reversible cross-linker DSP before cell lysis. As a 
control, a second plate of radiolabeled cells was incu­
bated under the same conditions without the cross­
linking reagent, and both plates of cells were har­
vested under denaturing conditions such that only the 
cross-linked interactions should remain intact. Immu­
noprecipitation reactions using antibodies to the dif­
ferent molecular chaperones were repeated, and the 
resultant immunoprecipitates were heated in Laemmli 
sample buffer containing extra reducing agent to re­
verse the cross-links before analysis by SDS-P AGE 
(Figure 5C). In each case, the different molecular chap­
erone antibodies were capable of capturing their re­
spective antigens after the cross-linking reaction, and 
excessive cross-linking of cellular proteins to any one 
chaperone was not apparent. When the same cross­
linking analysis was performed with pulse-labeled 
cells, antibodies to hsp70 again were the most efficient 
in coprecipitating the radiolabeled nascent chains 
(Figure 50). However, now antibodies to the cytosolic 
chaperonin (CCT) and hsp90 also captured some nas­
cent chains and/or newly synthesized proteins. In the 
case of C~T, one should note the coprecipitation of 
discrete bands representing proteins of approximately 
45, 50-55, and 100 kOa in mass (Figure 50, lane 2, 
+DSP). The two smaller proteins correspond in size to 
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full-length actin and tubulin (see next section). The 
nature of the 100-kDa band is unknown. When corn­
pared with control precipitations, little or no radioac­
tive material was observed to coprecipitate with anti­
bodies to the DnaJ homologue, hsp40, or to the 48-kDa 
protein (Figure 5C, lanes 3 and 4). 
The coprecipitation of nascent polypeptides with 
hsp70, as shown in the two pulse-labeling experiments 
of Figure 5, Band D, should not be compared quan­
titatively. In the experiment of Figure 5B, puromycin 
was used to accumulate a pool of truncated nascent 
polypeptides throughout the 20-rnin labeling period. 
In contrast, the number of incomplete nascent 
polypeptides in the cross-linking experiment could 
not exceed the absolute number of active ribosomes 
(Figure 5D). Nevertheless, all three approaches shown 
in Figure 4 and Figure 5, Band D, implicate hsp70 as 
being the major class of molecular chaperones that 
interact with nascent polypeptides in the cytosol of 
HeLa cells. Hsp90 was found in complexes with nas­
cent polypeptides only after stabilization of the inter­
action by cross-linking (Figure 5D, lane 5). 
CCT Binds Newly Synthesized Full-Length Actin 
and Tubulin In Vivo 
To identify the newly synthesized proteins that copre­
cipitated with CCT (Figure 5D, lane 2), the irnrnu­
noprecipitation experiments were repeated, and the 
resultant irnrnunoprecipitates were analyzed by two­
dimensional gel electrophoresis. For these experi­
ments, two plates of HeLa cells were labeled overnight 
and chased for 4.5 h. One plate was harvested imme­
diately. Culture medium containing fresh [35S]rnethi­
onine was added to the other plate, and newly syn­
thesized proteins were labeled for 15 min before lysing 
the cells. Irnrnunoprecipitation reactions were per­
formed under nondenaturing conditions using the an­
tibody to the-y-subunit of CCT. From the steady-state 
labeled cells, only the subunits comprising the cytoso­
lic chaperonin were precipitated (Figure 6B). Those 
subunits of CCT having more basic isoelectric points 
did not focus well in the pH range used for the first 
dimension. A trace amount of mature tubulin was 
observed to coprecipitate with CCT under these con­
ditions. From those cells provided the second 15-rnin 
labeling period; however, discernible amounts of 
newly synthesized actin and (a,{3)-tubulin were ob­
served to coprecipitate with the cytosolic chaperonin 
(Figure 6C). As expected, more of the -y-subunit of 
CCT also was precipitated, consistent with the capture 
of newly synthesized antigen that had not yet assem­
bled into mature CCT particles. 
The binding of CCT to full-length actin and tubulin 
(Figure 6C), along with the lack of CCT found in a 
complex with puromycin-released polypeptides (Fig­
ure 4A), is consistent with the idea that the cytosolic 
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chaperonin does not bind to its substrates in a cotrans­
lational manner. To address this issue directly, poly­
somes were isolated by velocity sedimentation and 
examined for the presence of cosedirnenting chaper­
ones. Analysis of the material by one-dimensional 
SDS-PAGE revealed numerous proteins, many of 
which corresponded in size to constituents of the large 
and small ribosomal subunits (Figure 6D, right). As 
expected, most of the basic ribosomal proteins were 
not resolved when analyzed by an equilibrium two­
dimensional gel using arnpholines in a slightly acidic 
pH range (Figure 6D, left). Proteins that fractionated 
with the polysornes included the cytosolic forms of 
hsp70, as well as a number of cytoskeletal proteins. 
The different protein constituents of CCT were not 
apparent within the isolated polysornes, suggesting 
that the cytosolic chaperonin does not interact with 
nascent polypeptides during their synthesis. 
Puromycin-released Polypeptides Bind 
Nonspecifically to Mature Proteins after Cell Lysis 
All of the results presented in this report indicate that 
members of the hsp70 family represent the most 
prominent molecular chaperones that interact with 
nascent polypeptides. However, significant amounts 
of both actin and tubulin consistently were observed 
to coprecipitate with the puromycin-released nascent 
chains. We suspected that the coprecipitation of these 
two abundant proteins may originate from nonspecific 
hydrophobic interactions with the nascent polypep­
tides because many of the truncated polypeptides are 
unable to fold into stable structures. To further char­
acterize this interaction, the effect of reducing the 
overall protein concentration of the cell lysate before 
the irnrnunoprecipitation analysis was examined for 
its consequences on nonspecific binding to purorny­
cyl-polypeptides. In the experiment shown in Figure 
7, each sample was programmed with the same 
amount of steady-state labeled cell lysate, irnrnuno­
precipitated with the same amount of puromycin an­
tibody, and washed under the same stringent condi­
tions. The only difference between the individual 
reactions was the initial dilution of the cell lysate 
before addition of the antibody. In the sample, where 
the overall protein concentration was the highest (1 :2 
dilution), we observed the greatest amount of copre­
cipitating proteins (Figure 7, lane 2). Further lysate 
dilutions of 1:6, 1:20, and 1:60 resulted in a corre­
sponding decrease in all coprecipitating proteins. At 
the highest dilution, hsp70 was clearly the major pro­
tein bound to purornycyl-polypeptides (Figure 7, lane 
5). The other coprecipitating proteins were, in fact, 
associated directly with the nascent polypeptides (and 
not binding nonspecifically to the antibody itself) be­
cause they were not precipitated when the antibody 
was blocked with free puromycin (compare Figure 7, 
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Figure 6. Complexes between CCT and newly synthesized full­
length actin and tubulin after a 15-min pulse with [3SS]methionine. 
Two-dimensional gel analysis of (A) total protein from cells steady­
state labeled with [35S)methionine and lysed in detergent; (B) im­
munoprecipitation of CCT from a 1:20 dilution of a lysate prepared 
identically to that shown in (A); (C) immunoprecipitation of CCT 
from cells which were labeled overnight with [3SS]methionine, 
chased 4.5 h in the absence of label, and then labeled again with 
PSSJmethionine for 15 min just before lysis. (0) Two-dimensional 
profile of isolated polysomes from HeLa cells that were steady-state 
labeled with [35S)methionine before hypotonic lysis (see Materials 
Figure 7. Nonspecific protein binding to puromycin-released nas­
cent polypeptides as a function of protein concentration. HeLa cells 
were steady-state labeled with PSSJmethionine and treated with 2 
JJ.M puromycin for 15 min after the chase period. For each immu­
noprecipitation (lanes 2-7), 50 JJ.l of the same lysate was used but 
diluted to different volumes with buffer A + 0.1% Triton X-100 
before addition of the antipuromycin antibody. (1) Starting lysate; 
(2) immunoprecipitation after 1:2 dilution; (3) 1:6 dilution; (4) 1:20 
dilution; (5) 1:60 dilution; (6) identical sample as lane 3, 1:6 dilution; 
(7) 1:6 dilution with addition of 100 JJ.M puromycin to block anti­
body. 
lanes 6 and 7). The increased detection of these pro­
teins in more concentrated samples may be attributed 
to both an increase in nonspecific binding per nascent 
chain and an increase in the number of nascent chains 
captured under conditions of higher antibody I anti­
gen concentrations (unpublished observations). It 
should be noted that the proteins identified in the 
two-dimensional gel of Figure 4A were coprecipitated 
from a lysate dilution of only 1:5, which explains the 
large amount of tubulin present in that particular sam­
ple. 
Dynamics and Affinity of Hsp70 Interaction with 
Puromycyl-Polypeptides 
With the exception of the cross-linking experiment, all 
of the previous results were dependent on the deple-
Figure 6 (cont). and Methods for details). A one-dimensional pro­
file of the same polysome sample is shown at right. Note that most 
of the basic ribosomal proteins do not focus in the pH range used for 
the first dimension. 
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tion of A TP in the lysate before immunoprecipitation 
analysis to stabilize the interaction of hsp70 with the 
puromycyl-polypeptides. To further examine the affinity 
of hsp70 for nascent polypeptides as a function of A TP 
levels, cells were disrupted in the presence of exogenous 
proteins, both native and abnormally folded. We ratio­
nalized that high concentrations of a nonnative protein, 
such as reduced and carboxymethylated BSA (RC-BSA) 
or a 5-casein, should compete with puromycyl-polypep­
tides for binding of hsp70 under conditions that facilitate 
dynamic interactions. In those samples where A TP levels 
were depleted immediately with apyrase during cell 
lysis, significant amounts of hsp70 were observed to 
coprecipitate with the puromycin-released nascent 
chains independent of the presence of the different pro­
tein supplements (Figure SA). A significant reduction in 
the "background" of other proteins that coprecipitated 
with the released nascent chains was observed, however, 
from the lysates containing RC-BSA, casein, or a sixfold 
excess of unlabeled HeLa cell lysate (Figure SA, lanes 
3-5, respectively). 
Proteins that coprecipitated with the puromycin an­
tibody from a control lysate and from a lysate pre­
pared in 10 mg/ml of RC-BSA were compared by 
two-dimensional gel electrophoresis (Figure S, D and 
E). Clearly, the presence of RC-BSA reduced the bind­
ing of tubulin and grp75 to puromycyl-polypeptides 
without affecting the coprecipitation of hsc70 and 
hsp70. The reduction in background coprecipitation 
was not observed after immunoprecipitation from a 
sample where RC-BSA had been added subsequent to 
cell lysis and ATP depletion (unpublished observa­
tion). When present during cell disruption (i.e., in the 
lysis buffer), RC-BSA and casein seem to intercept 
many of the proteins that coprecipitated with nascent 
polypeptides in a concentration-dependent, nonspe­
cific manner in Figure 7. These observations support 
the idea that hsp70 is the major relevant protein inter­
acting with puromycyl-polypeptides in the cytosol 
(before lysing the cells). 
When A TP was present during celllysis,labeled hsp70 
no longer was observed to coprecipitate with the puro­
mycin-released chains (Figure SB). Instead, only those 
proteins shown to bind nonspecifically were coprecipi­
tated. The amount of puromycin-released chains that 
were captured with the puromycin antibody was unaf­
fected by A TP depletion or by the presence of any of the 
exogenous proteins, as quantified in a parallel experi­
ment using pulse-labeled lysates (Eggers, 1997).In those 
lysates where A TP was initially present and then de­
pleted after a 10-min incubation, rebinding of the radio­
labeled hsp70 chaperone to the puromycin-released nas­
cent chains was observed. The extent of rebinding, 
however, varied as a function of the particular protein 
supplement (Figure 8C). In those lysates supplemented 
with either nothing or native BSA, hsp70 was observed 
to coprecipitate again with the puromycin-released 
chains (Figure 8C, lanes 1 and 2). In contrast, much less 
radiolabeled hsp70 was observed to coprecipitate with 
the puromycin-released chains in those lysates supple­
mented with 10 mg/ml of either RC-BSA or 0s-casein 
(Figure 8C, lanes 3 and 4). This is consistent with the idea 
that these nonnative protein supplements provide a vast 
excess of substrate for the hsp70 chaperone. Alterna­
tively, after the ATP-dependent release of hsp70 from 
the puromycin chains, the interacting sites on the chains 
themselves may become bound to the excess of added 
RC-BSA or casein (but not by the native BSA), resulting 
in less rebinding of chaperones as well as minimizing 
nonspecific interactions with labeled proteins. In the case 
where unlabeled HeLa cell lysate was present (Figure 
BC, lane 5), a significant reduction of the radiolabeled 
hsp70 chaperone was expected because the sixfold ex­
cess of unlabeled hsp70 could compete for rebinding to 
the puromycin-released nascent chains. Overall, the re­
sults of Figure S are consistent with the hypothesis that 
the interaction between members of the hsp70 family 
and nascent polypeptides is one of high affinity yet con­
stant dynamics in the presence of physiological concen­
trations of ATP. 
DISCUSSION 
It has been established that nascent polypeptides in­
teract with molecular chaperones during the early 
stages of their maturation. All of the available evi­
dence indicates that molecular chaperones influence 
protein maturation by minimizing "off-pathway" fold­
ing events, including aggregation. The first chaper­
ones shown to interact in a general way with nascent 
and newly synthesized proteins were members of the 
hsp70 family. The hsp70 chaperones, distributed 
throughout all intracellular compartments, seem to 
interact with nascent polypeptides still bound to the 
ribosome and with proteins as they are being trans­
ferred from the cytosol into the lumen of organelles. 
The interaction between a nascent polypeptide and its 
particular chaperone(s) is thought to stabilize tran­
siently exposed hydrophobic regions on the polypep­
tide until enough amino acids are incorporated into 
the growing chain (or translocated through an or­
ganellar membrane) to allow for the folding of a stable 
structure. 
Results of recent studies have led to the suggestion 
that the folding and maturation of newly synthesized 
proteins in the eukaryotic cytosol is facilitated by the 
sequential and cooperative interactions of molecular 
chaperones from multiple families. In the model of Hartl 
(1996), as a nascent polypeptide emerges from the ribo­
some, it is first recognized by and becomes bound to 
hsp40, a homologue of the bacterial DnaJ protein (Fryd­
man et al., 1994). DnaJ or hsp40 acts as a cofactor for the 
DnaK or cytosolic hsp70 chaperones, respectively, by 
stimulating their relatively weak A TPase activities. The 
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Figure 8. Affinity of hsp70 for puromycyl-polypeptides in the presence of exogenous proteins. Cells were steady-state labeled with 
[35S)methionine and treated with 2!LM puromycin for 30 min. Cells were lysed in buffer A+ 0.1% Triton X-100 supplemented with different 
exogenous proteins (numbered 1-5) and incubated with either (A) apyrase, (B) 10 mM MgATP, or (C) 10 mM MgATP for 10 min, followed 
by apyrase treatment. Control lanes on the left side of figure: (a) typical starting lysate; (b) immunoprecipitation with antibodies to 
hsc70/hsp70; (c) puromycin antibody blocked with free puromycin before immunoprecipitation. Antipuromycin immunoprecipitations were 
performed under nondenaturing conditions after 1:40 dilution of Iysates made in the presence of the following supplements: (1) no exogenous 
protein; (2) 10 mg/ ml BSA; (3) 10 mg/ml RC-BSA; (4) 10 mg/ml a.-casein; (5) sixfold excess of unlabeled HeLa protein from cells untreated 
with puromycin. (D) Two-dimensional gel analysis of proteins that coprecipitated with puromycyl-polypeptides from control cells lysed in 
the presence of apyrase and no exogenous protein. (E) Two-dimensional gel analysis of proteins that coprecipitated with puromycyl­
polypeptides from cells lysed in the presence of apyrase and 10 mg/ml RC-BSA. Protein identification numbers for the two-dimensional gels 
are the same as that in Figure 4: (2) grp75; (3) hsc70; (4) hsp70. 
substrate affinity of hsp70 (i.e., the ratio of bound to nascent polypeptide and presumably recruit hsp70 to 
unbound substrate at equilibrium) is reported to be the substrate with a bound molecule of ATP. Formation 
higher when the chaperone is in the ADP-bound confor­ of the ternary complex would result in the activation of 
mation, even though the kinetic rate constant for associ­ the ATPase activity of hsp70 (via the action of hsp40) 
ation with the substrate is higher for the ATP-bound and, therefore, in a more stable interaction between the 
conformation (Schmid et al., 1994; McCarty et al., 1995; hsp70 chaperone and the nascent polypeptide. Release of 
Theyssen et al., 1996). Thus, hsp40 would bind first to a the hsp70 chaperone from the nascent chain substrate 
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would require the return of hsp70 to its A TP-bound state 
via a nucleotide exchange event. For some proteins, the 
nascent chain would be transferred from hsp70 /hsp40 to 
another chaperone system, the high molecular weight 
cytosolic chaperonin complex (CCT), where synthesis 
and/or folding of the polypeptide would be completed. 
We have presented results obtained from a combi­
nation of metabolic labeling and immunoprecipitation 
techniques, including the use of an antibody to puro­
mycin, which were designed to verify the presence of 
various nascent polypeptide complexes that might be 
predicted from the preceding model. The use of pu­
romycin differs from other reported methods for ex­
amining interactions with nascent polypeptides in two 
major ways: (1) puromycyl-polypeptides are synthe­
sized as a population of randomly truncated polypep­
tides obtained from all the actively translated mRNAs 
in the cell, and, therefore, the complexes which are 
isolated and characterized should represent an aver­
age of all of the chaperone interactions that occur in 
vivo; and (2) the puromycin antibody allows one to 
capture these complexes without any experimental 
bias as to the identity of the bound chaperones before 
immunoprecipitation. 
We were hopeful that the use of the puromycin 
antibody would lead to the discovery of new chaper­
ones that had not been implicated previously in the 
process of protein folding and maturation. Instead, the 
well-known members of the hsp70 family were found 
to be the predominant species that coprecipitated with 
puromycyl-polypeptides (Figure 4). The higher degree 
of hsp70 binding relative to other selected chaperones 
was corroborated by the more traditional approach of 
using chaperone-specific antibodies to coprecipitate 
nascent polypeptides. Via pulse labeling and immu­
noprecipitation under conditions that maintain pro­
tein-protein interactions, antibodies specific for hsp70 
were found to be the most effective for the coprecipi­
tation of the puromycin-released nascent chains (Fig­
ure 5B). The cytosolic forms of hsp70 showed a strong 
affinity for puromycyl-polypeptides relative to RC­
BSA or casein when cells were lysed in the presence of 
a huge excess of these two abnormally folded proteins 
and simultaneously depleted of ATP (Figure SA). 
One caveat of using puromycin is that some relevant 
chaperone interactions might be lost after release of 
the nascent polypeptide because they occur only in the 
context of a translating ribosome. For example, it has 
been reported that two nascent chain binding compo­
nents, NAC and trigger factor, no longer can be de­
tected in association with nascent chains that have 
been released prematurely from the ribosome via pu­
romycin (Wiedmann et al., 1994; Valent et al., 1995; 
Hesterkamp et al., 1996). Consequently, a cross-linking 
approach was used in the absence of puromycin treat­
ment to address this issue. In those experiments using 
the membrane-permeable cross-linker OSP to stabilize 
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chaperone interactions before cell disruption, immu­
noprecipitation with antibodies to cytosolic hsp70 
again resulted in the highest capture of nascent chains 
relative to other chaperones (Figure 50). This result 
provides further evidence that hsp70 interacts with 
the nascent chains in a cotranslational manner and 
that this interaction may be captured without manip­
ulating the pool of ATP (i.e., under conditions that 
promote dynamic binding and release of hsp70). It is 
of interest that, after chemical cross-linking, antibodies 
to hsp90 were effective in coprecipitating a population 
of the radiolabeled nascent polypeptides (Figure 50, 
lane 5). Because hsp90 was not observed to bind to 
nascent chains by any other approach, we suspect that 
hsp90 interactions are sensitive to the method of cell 
lysis and immunoprecipitation in the absence of chem­
ical cross-linking. Hsp90 has been shown previously 
to affect the refolding of model proteins in vitro (Jakob 
et al., 1995; Freeman and Morimoto, 1996). 
Throughout the course of these studies, we were 
unable to detect any obvious interaction of the OnaJ 
homologue, hsp40, with the nascent polypeptides. An­
tibodies to hsp40 failed to coprecipitate any nascent or 
newly synthesized proteins (with or without the use of 
chemical cross-linking). Similarly, hsp40 was not ob­
served to coprecipitate when the puromycin-released 
nascent polypeptides were captured via the puromy­
cin antibody. Because the isoelectric point of hsp40 is 
very basic (pi 8.9; Ohtsuka, 1993), the puromycin im­
munoprecipitates shown in Figure 4 also were ana­
lyzed by nonequilibrium two-dimensional gel electro­
phoresis, but no hsp40 was detected (unpublished 
observation). These results, coupled with other studies 
(Nagata et al., manuscript in preparation), lead us to 
believe that hsp40 does not bind to nascent polypep­
tides. Furthermore, we did not observe any interac­
tions between nascent polypeptides and the p48 (Hip) 
protein, another suggested chaperone and cofactor for 
hsp70 (Hohfeld et al., 1995). 
With respect to the cytosolic chaperonin, a signifi­
cant amount of radioactive material was observed to 
coprecipitate with CCT after chemical cross-linking of 
cells that were labeled for only 5 min. For the most 
part, however, the coprecipitating material seemed to 
represent full-length proteins. Via analysis by two­
dimensional gels, these full-length proteins were 
shown to include newly synthesized actin and tubulin 
(Figure 6). A similar interaction has been reported in 
CHO cells using a different antibody to CCT (Stern­
licht et al., 1993). Collectively, our data strongly sup­
port the view that CCT interacts posttranslationally 
with a restricted "target range" of binding partners in 
vivo (Lewis et al., 1996). 
When puromycin-treated HeLa lysates were ana­
lyzed by gel filtration and velocity sedimentation, 
many of the puromycin-released nascent chains exhib­
ited native molecular masses much larger than their 
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apparent molecular mass as determined by SDS­
pAGE (Figure 2, A and B). Even though nonspecific 
interactions may contribute to the large and heterog­
enous size distribution, it should be noted that few of 
the puromycin-released nascent chains fractionated at 
a size that would indicate any interaction with CCT; 
native CCT is 800-950 kDa and sediments at 20 s 
(Frydman et al., 1992; Lewis et al., 1992). Results of 
limited proteolysis reactions revealed that many of the 
nascent proteins are maintained in a protected envi­
ronment by virtue of their interaction with other cel­
lular components (Figure 3). The fact that enhanced 
proteolysis of the nascent polypeptides was observed 
in those lysates supplemented with ATP is consistent 
with the known ATP dependence governing chaper­
one-substrate interactions, including those of the 
hsp70 family of chaperones. 
It is important to point out that we routinely ob­
served many of the puromycin-released chains inter­
acting with other abundant cellular proteins, espe­
cially actin and tubulin (Figure 4A). These interactions 
were greatly reduced by appropriate dilution of the 
initial lysate before immunoprecipitation (Figure 7) or 
by lysing the cells in the presence of RC-BSA or casein 
(Figure 8). Consequently, we suspect that nascent 
polypeptides have a propensity to interact nonspecifi­
cally with other cellular components. Indeed, it is this 
type of potential problem that likely accounts for the 
necessity of molecular chaperones in the early stages 
of protein synthesis and folding. We believe that the 
hsp70 chaperone fulfills this requirement by shielding 
the nascent chain from the crowded environment of 
the cytoplasm. The interaction of hsp70 with the nas­
cent chain, however, does not seem to be a static event. 
As a consequence of the relatively high levels of A TP 
in a healthy cell, the functional activity of hsp70 is 
likely characterized by repeated cycles of binding to 
and release from its nascent chain substrates. 
Presumably, dynamic chaperone interactions would 
allow protein folding to occur in a cotranslational 
manner. For example, during the early stages of trans­
lation, the nascent chain may not yet contain a suitable 
number of amino acids to allow for its productive 
folding. At this point in its synthesis, the nascent chain 
would be shielded, and thereby stabilized, via its in­
teraction with the hsp70 chaperone. As polypeptide 
synthesis proceeds, the hsp70 chaperone would con­
tinue to undergo A TP-dependent cycles of binding to 
and release from the growing polypeptide chain with­
out impeding the folding process. Once a sufficient 
number of amino acids have been incorporated to 
allow for complete folding of the amino-terminal do­
main, folding would commence after the next round 
of hsp70 release. This stable domain structure would 
no longer represent a target for hsp70 interaction. For 
those proteins containing multiple protein domains, 
one could envision the process being repeated during 
the course of synthesis and folding of each domain. 
For the majority of single domain proteins, however, 
we suspect that acquisition of the final folded state 
will occur only after the synthesis of the nearly com­
pleted polypeptide or after release of the full-length 
protein from the ribosome. By combining the in vivo 
approach described here with in vitro translation of 
specific model proteins, it should be possible to fur­
ther elucidate the properties of nascent polypeptides 
and their interactions with molecular chaperones. 
ACKNOWLEDGMENTS 
D.K.E. acknowledges past support from the Genentech Foundation 
for Biomedical Sciences through the ARCS Foundation, Northern 
California Chapter. Antibodies to p48 were a gift from D.F. Smith 
(University of Nebraska Medical Center, Omaha, NE), and the P5 
antibody to CCT was kindly donated by E.C. Joly and V. Bibor­
Hardy (lnstitut du Cancer de Montreal, Montreal, Quebec, Canada). 
We thank A. Kabiling for expert help in completing the two-dimen­
sional gels. This work was supported by grants to W.J.W. from the 
National Institutes of Health (5 R01 GM33551) and National Science 
Foundation (MCB-9421946). 
REFERENCES 
Anfinsen, C.B. (1973). Principles that govern the folding of protein 
chains. Science 181, 223-230. 
Beck, S.C., and De Maio, A. (1994). Stabilization of protein synthesis 
in thermotolerant cells during heat shock. J. Biol. Chern. 269,21803­
21811. 
Becker, J., and Craig, E.A. (1994). Heat-shock proteins as molecular 
chaperones. Eur. J. Biochem. 219, 11-23. 
Beckmann, R.P., Mizzen, L.A., and Welch, W.J. (1990). Interaction of 
hsp70 with newly synthesized proteins: implications for protein 
folding and assembly. Science 248, 850-854. 
Blattler, D.P., Gamer, F., Van Slyke, K., and Bradley, A. (1972). 
Quantitative electrophoresis in polyacrylamide gels of 2-40%. J. 
Chromatogr. 64, 147-155. 
Brown, C.R., Martin, R.L., Hansen, W.J., Beckmann, R.P., and 
Welch, W.J. (1993). The constitutive and stress inducible forms of 
hsp70 exhibit functional similarities and interact with one another in 
an ATP-dependent fashion. J. Cell Biol. 120, 1101-1112. 
Buchner, J. (1996). Supervising the fold: functional principles of 
molecular chaperones. FASEB J. 10, 10-19. 
Dobrzynski, J.K., Stemlicht, M.L., Parr, G.W., and Stemlicht, H. 
(1996). Newly synthesized /3-tubulin demonstrates domain-specific 
interactions with the cytosolic chaperonin. Biochemistry 35, 15870­
15882. 
Eggers, O.K. (1997). Characterization of nascent polypeptides and 
their molecular chaperones in mammalian cells. Ph.D. thesis, Uni­
versity of California, San Francisco. 
Freeman, B.C., and Morimoto, R.I. (1996). The human cytosolic 
molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct 
roles in recognition of a non-native protein and protein refolding. 
EMBO J. 15, 2969-2979. 
Frydman, J., and Hartl, F.U. (1996). Principles of chaperone-assisted 
protein folding: Differences between in vitro and in vivo mecha­
nisms. Science 272, 1497-1501. 
Frydman, J., Nimmesgem, E., Erdjument-Bromage, H., Wall, J.S., 
Tempst, P., and Hartl, F.U. (1992). Function in protein folding of 
Molecular Biology of the Cell 1572 
TRiC, a cytosolic ring complex containing TCP-1 and structurally 
related subunits. EMBO J. 11, 4767-4778. 
Frydman, J., Nimmesgern, E., Ohtsuka, K., and Hartl, F.U. (1994). 
Folding of nascent polypeptide chains in a high molecular mass 
assembly with molecular chaperones. Nature 370, 111-117. 
Georgopoulos, C., and Welch, W.J. (1993). Role of the major heat 
shock proteins as molecular chaperones. Annu. Rev. Cell Bioi. 9, 
601-634. 
Gething, M.J., and Sambrook, J. (1992). Protein folding in the cell. 
Nature 355, 33-45. 
Hansen, W.J., Lingappa, V.R., and Welch, W.J. (1994). Complex 
environment of nascent polypeptide chains. J. Bioi. Chern. 269, 
26610-26613. 
Hartl, F.U. (1996). Molecular chaperones in cellular protein folding. 
Nature 381, 571-580. 
Hendrick, J.P., and Hartl, F.U. (1995). The role of molecular chap­
erones in protein folding. FASEB J. 9, 1559-1569. 
Hendrick, J.P., Langer, T., Davis, T.A., Hartl, F.U., and Wiedmann, 
M. (1993). Control of folding and membrane translocation by bind­
ing of the chaperone DnaJ to nascent polypeptides. Proc. Natl. Acad. 
Sci. USA 90, 10216-10220. 
Hesterkamp, T., Hauser, S., Lutcke, H., and Bukau, B. (1996). E. coli 
trigger factor is a prolyl isomerase that associates with nascent 
polypeptide chains. Proc. Natl. Acad. Sci. USA 93, 4437-4441. 
Hiihfeld, J., Minami, Y., and Hartl, F.U. (1995). Hip, a novel cochap­
erone involved in the eukaryotic hsc70/hsp40 reaction cycle. Cell 
83, 589-598. 
Jakob, U., Lilie, H., Meyer, 1., and Buchner, J. (1995). Transient 
interaction of hsp90 with early unfolding intermediates of citrate 
synthase. J. Bioi. Chern. 270, 7288-7294. 
Joly, E.C., Tremblay, E., Tanguay, R.M., Wu, Y., and Bibor-Hardy, V. 
(1994). TRiC-P5, a novel TCP1-related protein, is localized in the 
cytoplasm and in the nuclear matrix. J. Cell Science 107, 2851-2859. 
Kubota, H., Hynes, G., and Willison, K. (1995). The chaperonin 
containing t-complex polypeptide 1 (TCP-1). Eur. J. Biochem. 230, 
3-16. 
Kudlicki, W., Odom, O.W., Kramer, G., and Hardesty, B. (1994). 
Chaperone-dependent folding and activation of ribosome-bound 
nascent rhodanese. J. Mol. Bioi. 244, 319-331. 
Lai, B.-T., Chin, N.W., Stanek, A.E., Keh, W., and Lanks, K.W. 
(1984). Quantitation and intracellular localization of the 85K heat 
shock protein by using monoclonal and polyclonal antibodies. Mol. 
Cell. Bioi. 4, 2802-2810. 
Langer, T., Lu, C., Echols, H., Flanagan, J., Hayer, M.K., and Hartl, 
F.U. (1992). Successive action of DnaK, DnaJ and GroEL along the 
pathway of chaperone-mediated protein folding. Nature 356, 683­
689. 
Lewis, S.A., Tian, G., Vainberg, I.E., and Cowan, N.J. (1996). Chap­
eronin-mediated folding of actin and tubulin. J. Cell Bioi. 132, 1-4. 
Lewis, V.A., Hynes, G.M., Zheng, D., Saibil, H., and Willison, K. 
(1992). T-complex polypeptide-I is a subunit of a heteromeric par­
ticle in the eukaryotic cytosol. Nature 358, 249-252. 
Lingappa, J.R., Martin, R.L., Wong, M.L., Ganem, D., Welch, W.J., 
and Lingappa, V.R. (1994). A eukaryotic cytosolic chaperonin is 
associated with a high molecular weight intermediate in the assem­
bly of hepatitis B virus capsid, a multimeric particle. J. Cell Bioi. 125, 
99-111. 
McCarty, J.S., Buchberger, A., Reinstein, J., and Bukau, B. (1995). 
The role of ATP in the functional cycle of DnaK chaperone system. 
J. Mol. Bioi. 249, 126-137. 
Nascent Polypeptides and Their Chaperones 
Milarski, K.L., Welch, W.J., and Morimoto, R.I. (1989). Cell cycle­
dependent association of hsp70 with specific cellular proteins. J. Cell 
Bioi. 108, 413-423. 
Nelson, R.J., Ziegelhoffer, T., Nicolet, C., Werner-Washburne, M., 
and Craig, E.A. (1992). The translation machinery and 70 kD heat 
shock protein cooperate in protein synthesis. Cell 71, 97-105. 
Ohtsuka, K. (1993). Cloning of a eDNA for heat-shock protein hsp40, 
a human homologue of bacterial DnaJ. Biochem. Biophys. Res. 
Commun. 197, 235-240. 
Palleros, D.R., Welch, W.J., and Fink, A.L. (1991). Interaction of 
hsp70 with unfolded proteins: effects of temperature and nucleo­
tides on the kinetics of binding. Proc. Natl. Acad. Sci. USA 88, 
5719-5723. 
Prapapanich, V., Chen, S., Nair, S.C., Rimerman, R.A., and Smith, 
D.F. (1996). Molecular cloning of human p48, a transient component 
of progesterone receptor complexes and an hsp-70 binding protein. 
Mol. Endocrinol. 10, 420-431. 
Reid, B.G., and Flynn, G.C. (1996). GroEL binds to and unfolds 
rhodanese posttranslationally. J. Bioi. Chern. 271, 7212-7217. 
Sadis, S., and Hightower, L.E. (1992). Unfolded proteins stimulate 
molecular chaperone hsc70 A TPase by accelerating ADP I ATP ex­
change. Biochemistry 31, 9406-9412. 
Safiejko-Mroczka, B., and Bell, P.B. (1996). Bifunctional protein 
cross-linking reagents improve labeling of cytoskeletal proteins for 
qualitative and quantitative fluorescence microscopy. J. Histochem. 
Cytochem. 44, 641-656. 
Schmid, D., Baici, A., Gehring, H., and Christen, P. (1994). Kinetics 
of molecular chaperone action. Science 263, 971-973. 
Schroder, H., Langer, T., Hartl, F.U., and Bukau, B. (1993). DnaK, 
DnaJ and GrpE form a cellular chaperone machinery capable of 
repairing heat-induced protein damage. EMBO J. 12, 4137-4144. 
Schumacher, R.J., Hurst, R., Sullivan, W.P., McMahon, N.J., Toft, 
D.O., and Matts, R.L. (1994). ATP-dependent chaperoning activity 
of reticulocyte lysate. J. Bioi. Chern. 269, 9493-9499. 
Sternlicht, H., Farr, G.W., Sternlicht, M.L., Driscoll, J.K., Willison, K., 
and Yaffe, M.B. (1993). The t-complex polypeptide 1 complex is a 
chaperonin for tubulin and actin in vivo. Proc. Natl. Acad. Sci. USA 
90, 9422-9426. 
Szabo, A., Langer, T., Schroder, H., Flanagan, J., Bukau, B., and 
Hartl, F.U. (1994). The ATP hydrolysis-dependent reaction cycle of 
the E. coli hsp70 system: DnaK, DnaJ, and GrpE. Proc. Natl. Acad. 
Sci. USA 91, 10345-10349. 
Theyssen, H., Schuster, H.P., Packschies, L., Bukau, B., and Rein­
stein, J. (1996). The second step of ATP binding to DnaK induces 
peptide release. J. Mol. Bioi. 263, 657-670. 
Tian, G., Huang, Y., Rommelaere, H., Vandekerckhove, J., Ampe, C., 
and Cowan, N.J. (1996). Pathway leading to correctly folded {3­
tubulin. Cell 86, 287-296. 
Valent, Q.A., Kendall, D.A., High, S., Kusters, R., Oudega, B., and 
Luirink, J. (1995). Early events in preprotein recognition in E. coli: 
interaction of SRP and trigger factor with nascent polypeptides. 
EMBO J. 14, 5494-5505. 
Wiedmann, B., Sakai, H., Davis, T.A., and Wiedmann, M. (1994). A 
protein complex required for signal-sequence-specific sorting and 
translocation. Nature 370, 434-440. 
Willison, K., Lewis, V., Zuckerman, K.S., Cordell, J., Dean, C., Miller, 
K., Lyon, M.F., and Marsh, M. (1989). The t complex polypeptide 1 
(TCP-1) is associated with the cytoplasmic aspect of Golgi mem­
branes. Cell 57, 621-632. 
Vol. 8, August 1997 1573 
